Godavari Biorefineries’ biotech arm, Sathgen Therapeutics, has secured a Chinese patent for its anti-cancer molecule Hydroxy-1,4-Naphthalenedione.
The compound shows strong in vitro efficacy against cancer and cancer stem cells.
GBL continues to expand globally, focusing on innovative cancer and antiviral therapies through advanced translational research.